You are here

  • Home
  • Archive
  • Volume 104, Issue 7
  • Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy

Article metrics

Article menu
Download PDFPDF
Clinical science
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy

 

Online download statistics by month:

Online download statistics by month: October 2019 to March 2023

AbstractFullPdf
Oct 20191129493471
Nov 2019213112261197
Dec 20193389475
Jan 2020119165
Feb 202072126
Mar 2020792513
Apr 202085192
May 2020863212
Jun 20204435227
Jul 20204487033
Aug 20201403110
Sep 20201895019
Oct 2020111319
Nov 20207864
Dec 202013078
Jan 2021249169
Feb 202112867
Mar 20218234
Apr 202114958
May 202140108
Jun 2021722
Jul 2021741
Aug 20211064
Sep 20211083
Oct 20217563
Nov 202162147
Dec 202163129
Jan 202210623
Feb 20226232
Mar 20226569
Apr 20225988
May 20229955
Jun 20226083
Jul 20227482
Aug 20226971
Sep 202285124
Oct 20226921
Nov 20228541
Dec 202242106
Jan 20234043
Feb 20237912
Total745423362006